# MedImmune

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/medimmune/

## Facts

| Field | Value |
| --- | --- |
| Country | GB |
| Description | British-Swedish pharmaceutical company |
| OpenAlex ID | https://openalex.org/F4320322783 |
| ROR ID | https://ror.org/04r9x1a08 |
| Works | 944 |

## Funder papers

- [Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study](https://scholariq.org/papers/durvalumab-in-combination-with-olaparib-in-patients-with-relapsed-sclc-results/)
- [High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome](https://scholariq.org/papers/high-prevalence-of-somatic-oncogenic-driver-alterations-in-patients-with-nsclc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.